Study Stopped
Methodology of subject enrollment would require significant modification.
Integrative Cardiac Health Project Cognitive-Behavior Therapy for Insomnia
CBT-I
1 other identifier
interventional
6
1 country
1
Brief Summary
This study investigates the feasibility, acceptability, and effectiveness of adding Cognitive-Behavioral Therapy for Insomnia (CBT-I) to the standard care received at the Integrative Cardiac Health Project (ICHP) on insomnia symptoms and severity. ICHP is an established cardiovascular disease prevention program to reduce cardiovascular disease risk through the adoption of lifestyle changes related to improvements in diet, stress, sleep, and exercise. The study will be conducted among patients with insomnia who are already enrolled in the ICHP cardiovascular risk prevention program. This is a single-center study, prospective, randomized, controlled, interventional trial within ICHP at the Walter Reed National Military Medical Center (WRNMMC). To conduct both phases of the study, up to 76 total male and female patients enrolled in ICHP who meet criteria for insomnia will be recruited. Participants who meet inclusion and exclusion criteria for this study, and consent to participate, will be randomized to one of two conditions: (1) ICHP, or (2) ICHP + CBT-I treatment. CBT-I treatment will consist of four in-person appointments and two telephone appointments.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2015
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 29, 2015
CompletedFirst Submitted
Initial submission to the registry
April 18, 2016
CompletedFirst Posted
Study publicly available on registry
May 20, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 11, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
July 11, 2016
CompletedSeptember 11, 2018
September 1, 2018
9 months
April 18, 2016
September 7, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Sleep Efficiency
collected through sleep diary and actigraphy
2 months, 4 months, and 6 months
Secondary Outcomes (7)
Insomnia Severity Index
2 months, 4 months, and 6 months
Perceived Stress
2 months, 4 months, and 6 months
Patient Health Questionnaire-9
2 months, 4 months, and 6 months
Multidimensional Fatigue Inventory
2 months, 4 months, and 6 months
Epworth Sleepiness Scale
2 months, 4 months, and 6 months
- +2 more secondary outcomes
Other Outcomes (2)
Insomnia Treatment Acceptability Scale-Behavior Subscale
2 weeks and again at 2 months
Insomnia Treatment Evaluation Measure-Revised
2 months
Study Arms (2)
ICHP + CBT-I
EXPERIMENTALParticipants in this arm will receive the usual care (ICHP program) plus 6 Cognitive-Behavior Therapy for Insomnia (CBT-I) treatment sessions. Four of the treatment sessions will be in person and two will be over the phone.
ICHP Only
NO INTERVENTIONParticipants in this arm will receive the usual care (ICHP program).
Interventions
Eligibility Criteria
You may qualify if:
- Age 18 or older, Tricare beneficiary, participation in ICHP
- Sleep-onset or maintenance insomnia, defined as sleep-onset latency (SOL; time it takes to fall asleep) and/or wake after sleep onset (WASO; time spent awake after falling asleep) longer than 30 minutes per night at least 3 nights per week
- Insomnia duration of at least 3 months
- A complaint of at least 1 negative effect during waking hours (e.g., fatigue, impaired functioning, mood disturbances) that is attributed to insomnia
- Score of 8 or greater on the Insomnia Severity Index
- Pittsburgh Sleep Quality Index (PSQI) score of \> 5
You may not qualify if:
- Previous participation in the ICHP program
- Use of stimulant medications or acute high dose of steroids
- Suicidal ideation, as determined by a score of 1 or greater on question #9 of the Patient Health Questionnaire-9 (PHQ-9)
- Concurrent psychological or behavioral treatment for insomnia
- Current pregnancy by history, or plans to become pregnant in the next 6 months (excluded because of sleep difficulties which often occur during pregnancy that could confound the results)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Integrative Cardiac Health Project, Walter Reed National Military Medical Center
Bethesda, Maryland, 20889, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Todd C Villines, MD
Walter Reed National Military Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 18, 2016
First Posted
May 20, 2016
Study Start
October 29, 2015
Primary Completion
July 11, 2016
Study Completion
July 11, 2016
Last Updated
September 11, 2018
Record last verified: 2018-09
Data Sharing
- IPD Sharing
- Will not share